OVERCOMING RESISTANCE TO NK-MEDIATED LYSIS IN ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS

被引：0
|
作者：
Dahut, Madeline [1 ]
Fousek, Kristen [1 ]
Horn, Lucas [1 ]
Qin, Haiyan [1 ]
Schlom, Jeffrey [1 ]
Palena, Claudia [1 ]
机构：
[1] Natl Canc Inst, Bethesda, MD USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0909
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
909
引用
收藏
页码：A947 / A947
页数：1
相关论文
共 50 条
  • [1] Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis
    Dahut, Madeline
    Fousek, Kristen
    Horn, Lucas A.
    Angstadt, Shantel
    Qin, Haiyan
    Hamilton, Duane H.
    Schlom, Jeffrey
    Palena, Claudia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [2] Pathways to enzalutamide resistance: An analysis of proteomic changes in enzalutamide-resistant prostate cancer cells
    Molokwu, Chidi N.
    Kristensen, Anders
    Sutton, Chris
    CANCER RESEARCH, 2024, 84 (03)
  • [3] OVERCOMING ENZALUTAMIDE-RESISTANT WITH A NOVEL ANTI-AR PEPTIDE IN PROSTATE CANCER CELLS
    Zainfeld, Daniel
    Chen, Ruibao
    Thrasher, J. Brantley
    Li, Benyi
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1095 - E1095
  • [4] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [5] NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells
    Farah, Elia
    Li, Chaohao
    Cheng, Lijun
    Kong, Yifan
    Lanman, Nadia A.
    Pascuzzi, Pete
    Lorenz, Gabrielle Renee
    Zhang, Yanquan
    Ahmad, Nihal
    Li, Lang
    Ratliff, Tim
    Liu, Xiaoqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (21) : 8543 - 8554
  • [6] AMINO ACID TRANSPORT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Seyan, Zheyar J.
    Wolpert, John
    Stroever, Stephanie
    de Riese, Werner T. W.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E49 - E49
  • [7] Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer
    Thomas, Lewis
    Baratchian, Mehdi
    Sharifi, Nima
    EUROPEAN UROLOGY, 2020, 77 (02) : 156 - 157
  • [8] Aberrant Super-Enhancer Landscape in Enzalutamide-Resistant Prostate Cancer Cells
    Cai, Chao
    Liu, Qinwei
    Shan, Haoran
    Zhong, Chuanfan
    Chen, Guidong
    Cai, Zhouda
    Zheng, Yu
    Lu, Jianming
    Tang, Jiaojiao
    Lin, Zhuoyuan
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (06) : 243 - 256
  • [9] Overcoming EGFR and ERK-mediated resistance to enzalutamide in castraction-resistant prostate cancer
    Steele, Thomas M.
    Jathal, Maitreyee K.
    Siddiqui, Salma
    Qin, Sisi
    Tepper, Clifford G.
    White, Ralph W. deVere
    Kohli, Manish
    Wang, Liewei
    Gao, Allen C.
    Ghosh, Paramita M.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
    Tucci, Marcello
    Zichi, Clizia
    Buttigliero, Consuelo
    Vignani, Francesca
    Scagliotti, Giorgio V.
    Di Maio, Massimo
    ONCOTARGETS AND THERAPY, 2018, 11 : 7353 - 7368
12345